HD-tDCS + Speech Therapy for Aphasia

N/A

Recruiting

Research Sponsored by Medical College of Wisconsin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must be adults and have English-language fluency

Patients must be 18 or older

Must not have

Neurologic disease (e.g. idiopathic epilepsy, seizure disorders that are not well managed, Parkinson's disease, ALS)

Suspected or diagnosed uncorrectable hearing or vision difficulties, or developmental disabilities (i.e. intellectual disability or learning disability)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 time points: pre-assessment, 10 weeks post-therapy cycle a and 10 weeks post-therapy cycle b

Awards & highlights

No Placebo-Only Group

Summary

This trial will look at how mild electricity and speech therapy can help stroke survivors with language issues. #strokerecovery

Who is the study for?

This trial is for adults over 18 with aphasia from left-sided brain damage like a stroke, who can speak English and are MRI-eligible. It's not for those with advanced neurodegenerative diseases, unmanaged seizure disorders, severe mental health issues, major hearing or vision problems, developmental disabilities, or MRI contraindications such as metal implants.

What is being tested?

The study tests if mild electrical stimulation to the brain (HD-tDCS) combined with speech therapy helps language recovery in people who have speech difficulties after a stroke. Participants will receive this combination treatment and their progress will be monitored.

What are the potential side effects?

Possible side effects of HD-tDCS may include discomfort at the electrode site on the head, itching or tingling during stimulation, headache, fatigue and in rare cases nausea. Speech therapy typically does not have physical side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult who speaks and understands English fluently.

Select...

I am 18 years old or older.

Select...

I have difficulty with language due to a stroke or tumor on the left side of my brain.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a neurological condition like epilepsy, Parkinson's, or ALS.

Select...

I have hearing, vision difficulties, or a learning disability that cannot be corrected.

Select...

I have advanced Alzheimer's disease.

Select...

I am either younger than 18 or older than 85.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 time points: pre-assessment, 10 weeks post-therapy cycle a and 10 weeks post-therapy cycle b

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 time points: pre-assessment, 10 weeks post-therapy cycle a and 10 weeks post-therapy cycle b

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 time points: pre-assessment, 10 weeks post-therapy cycle a and 10 weeks post-therapy cycle b for reporting.